FIBMS MSc Biomedical Science - Cellular Pathology. Have worked in the Pharmaceutical industry since 1979;

Year |
Subject |
2003 |
Image analysis |
2004 |
Basic microscopy., including: microscope alignment and basic light-, phase contrast-, polarising- and dark field- microscopy |
2005 |
Basic pathology |
2006 |
Identification of tissue structures using special stains |
2007 |
Basic Immunohistochemistry Techniques |
2008 |
Basics of Molecular Pathology techniques and will include: In situ hybridisation and Western blots. |
2009 |
Antigen Retrieval Techniques for Immunohistochemistry |
2010 |
Haematoxylin & Eosin and specialised stains |
2011 |
Basic tissue recognition in histopathology |
2012 |
Image analysis |
2013 |
Basic tissue recognition in histopathology |
2015 |
Basic Histology/Basic Histopathology |
Special Stains and Artefacts |
|
2017 |
Basic tissue recognition, RNA ISH assays, SHG imaging, Tissue multiplexing, Histology and Mass spectrometry |
2018 |
Basic Microtomy, RNAscope, Image analysis discussion forum, Immunofluorescence multiplexing, Immunophenotyping |
FIBMS MSc Biomedical Science - Cellular Pathology. Have worked in the Pharmaceutical industry since 1979;
Lloyd has been an active supporter of the European Histopathology Forum for many years and currently holds the position of Vice Chairperson.
32 years experience in pharmaceutical contract research at Covance Laboratories in Harrogate; from a bench scientist to managing small specialist and larger general laboratory teams.
Senior Cellular Pathology Scientist
MSc FIBMS >25 years’ experience in the Histology department at a large CRO.
Experience in pharmaceutical company ABPI qualified and also in industrial food related microbiology.
Over 18 years’ experience in Sales, marketing, product management and export for dedicated Histotechnology companies.
Edward has a strong background in histology and molecular pathology having held several roles within the NHS and the private...
Hitesh has been recently joined the committee of the European Histopathology Forum. He has over 16 years’ of global experience in Non-clinical safety assessment in toxicology as well as pathology areas in the Pharmaceutical R&D (India & UK)
Currently Pathology Sciences Lab Manager at AstraZeneca since March 2016, based at the new Cambridge site and responsible for the EU Histology team in the Drug Safety and Metabolism organisation.
To be updated soon